A research study conducted at the Sultan Qaboos Comprehensive Cancer Care & Research Centre (SQCCCRC) discovered that certain genetic variants in the DPYD gene could predict severe toxicity reactions among Omani patients with gastrointestinal tumors, including neutropenia and diarrhea.
Imagine having the ability to look deep into our genetic code to uncover the secrets held within our DNA. This is no longer just a thought for the future, but a reality at the Sultan Qaboos Comprehensive Cancer Care and Research Center (SQCCCRC) in Oman. Our dedicated research scientists have introduced a groundbreaking test that reads our genetic blueprint, offering hope and innovation in cancer diagnosis and treatment research.
One of the major privileges of clinicians working in world-class research centres is the opportunity to participate in clinical research. Most patients who come to such institutions are willing to take part in meaningful studies that could potentially revolutionise medical practice and enhance their own and other patients’ treatment outcomes.
The Sultan Qaboos Comprehensive Cancer Care & Research Centre has initiated four clinical trials since the inception of the Clinical Trials Department, which is the first of its kind in the Sultanate of Oman. Clinical research is another way to find the latest ways to treat cancer and aims to study the impact of new treatments that have not yet been proven in order to validate and approve them.
Ongoing Research Ongoing Researches 2021 Principal Investigator Research Title Ms. Bushra Mustafa, Pharmacy, SQCCCRC Effect of Molecular Markers on Fluorouracil and Capecitabine Pharmacokinetics and Clinical Outcomes. Dr. Nwal Al Muhaijri, Holistic Care, SQCCCRC Personality Types, Attachment Styles, Empathy and Quality of Life among Clinicians at Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC). Prof. …
Input your search keywords.
